President and CEO, Civica Rx
Sunday, Nov. 17, 2019 • 3:00 PM–5:00 PM
Martin VanTrieste is a former chief quality officer at Amgen who was most recently named a “Champion of Change” on The Medicine Maker’s Power List for his role in leading Civica, a new, not-for-profit enterprise created to stabilize the supply of essential generic medications. Martin brings over 35 years in the industry, with comprehensive experience in biopharmaceutical manufacturing, quality systems and related government regulations in the US and around the world.
Prior to joining Amgen, VanTrieste was with Bayer Healthcare’s Biological Products Division as vice president of worldwide quality and Abbott Laboratories as the vice
president of quality assurance for the Hospital Products Division.
VanTrieste is the founder of Rx-360, an international nonprofit organization that enhances patient safety by increasing security and quality in the biopharmaceutical supply chain. He has also served as the Chairman of the Parenteral Drug Association (PDA) Board of Directors. The PDA has 10,000 members and its mission is to advance pharmaceutical/biopharmaceutical manufacturing science and regulation so members can better serve patients.
PharmaVoice has named VanTrieste one of the 100 most inspiring people in the pharmaceutical industry, calling him “a man with a mission.” The Medicine Maker has previously named him one of the most influential people in the world of drug development and manufacture saying he “is known throughout industry as a change agent and influencer for his work on advancing pharmaceutical manufacturing, quality and helping to ensure a more reliable supply of high-quality medicines.”
VanTrieste earned a Pharmacy degree from Temple University School of Pharmacy.